Literature DB >> 9167010

Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine.

M Amadori1, G Volpe, P Defilippi, C Berneri.   

Abstract

BHK-21 c13 monolayer and suspension cells were investigated with regard to some phenotypic features which could bear on the quality of foot-and-mouth disease virus (FMDV) antigen produced in them. Despite good viability, suspension cells differed from monolayer cells in fundamental features of susceptibility to FMDV. Most important, FMD virus particles grown in suspension cells at high passage levels were shown to be largely degraded following inactivation with an aziridine compound. Suspension cells were characterised by a downregulation in the surface expression of both alpha 5 and alpha V integrin chains. According to the results of binding assays, both integrins could act as FMDV receptors on BHK-21 c13 cells. Reduced surface expression of integrins was correlated with disappearance of actin stress fibres, which would play a role in regular encapsidation of viral RNA and hence in stability of virus particles. With regard to FMD vaccine production, practical suggestions are put forward to evaluate the quality of BHK-21 c13 cells and FMDV Ag, which must prove stable during downstream processing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9167010     DOI: 10.1006/biol.1996.0061

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  8 in total

1.  VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment.

Authors:  Max Ciarlet; Sue E Crawford; Elly Cheng; Sarah E Blutt; Daren A Rice; Jeffrey M Bergelson; Mary K Estes
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

3.  Adaption of FMDV Asia-1 to Suspension Culture: Cell Resistance Is Overcome by Virus Capsid Alterations.

Authors:  Veronika Dill; Bernd Hoffmann; Aline Zimmer; Martin Beer; Michael Eschbaumer
Journal:  Viruses       Date:  2017-08-18       Impact factor: 5.048

4.  Knockout of HDAC9 Gene Enhances Foot-and-Mouth Disease Virus Replication.

Authors:  Shitong Hou; Xiangwei Wang; Shanhui Ren; Xuelian Meng; Xiangping Yin; Jie Zhang; Kazimierz Tarasiuk; Zygmunt Pejsak; Tao Jiang; Ruoqing Mao; Yongguang Zhang; Yuefeng Sun
Journal:  Front Microbiol       Date:  2022-02-18       Impact factor: 5.640

5.  Influence of cell type and cell culture media on the propagation of foot-and-mouth disease virus with regard to vaccine quality.

Authors:  Veronika Dill; Bernd Hoffmann; Aline Zimmer; Martin Beer; Michael Eschbaumer
Journal:  Virol J       Date:  2018-03-16       Impact factor: 4.099

6.  Analysis of Amino Acid Mutations of the Foot-and-Mouth Disease Virus Serotype O Using both Heparan Sulfate and JMJD6 Receptors.

Authors:  Gyeongmin Lee; Ji-Hyeon Hwang; Aro Kim; Jong-Hyeon Park; Min Ja Lee; Byounghan Kim; Su-Mi Kim
Journal:  Viruses       Date:  2020-09-10       Impact factor: 5.048

Review 7.  Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2.

Authors:  Inmaculada Sanclemente-Alaman; Lidia Moreno-Jiménez; María Soledad Benito-Martín; Alejandro Canales-Aguirre; Jordi A Matías-Guiu; Jorge Matías-Guiu; Ulises Gómez-Pinedo
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

8.  A Vaccine Strain of the A/ASIA/Sea-97 Lineage of Foot-and-Mouth Disease Virus with a Single Amino Acid Substitution in the P1 Region That Is Adapted to Suspension Culture Provides High Immunogenicity.

Authors:  Ji-Hyeon Hwang; Gyeongmin Lee; Aro Kim; Jong-Hyeon Park; Min Ja Lee; Byounghan Kim; Su-Mi Kim
Journal:  Vaccines (Basel)       Date:  2021-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.